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Abstract The aim of this study was to obtain patient and par-
ent perspectives on genetic evaluation of hearing loss, in order
to identify motivators, expectations, and barriers. Three focus
groups were conducted following a semi-structured discussion
guide, led by an independent moderator. Participants were hear-
ing parents of children with permanent hearing loss or deaf
adults. Qualitative content analysis was used to develop a code-
book and identify major themes and subthemes. Participant
views were compared to national guidelines. The 28 partici-
pants comprised 23 parents representing 21 unique families
and 5 deaf adults. 13/21 families and 0/5 adults reported co-
morbidities, 4/21 families and 3/5 adults had a positive family
history, and 12/21 families versus 0/5 adults had utilized genet-
ics services. A common theme among adults and parents was a
curiosity as to the cause of hearing loss. Parents were motivated
to detect comorbidities and optimize care for hearing loss.
Some parents felt overwhelmed by the hearing loss and unpre-
pared to pursue early genetic evaluation as recommended in
guidelines. Several reported positive experiences following
genetics consultation, while others reported unease and unmet
expectations. Notably, both parents and adults expressed am-
bivalence regarding the desire for genetic knowledge. Financial
concerns and difficulties obtaining a referral were cited as ex-
trinsic barriers. For parents of children with hearing loss, both
the presence of comorbidities and a positive family history were
drivers of genetics consultation and/or genetic testing. We iden-
tified educational opportunities for both patients and providers
that would improve informed decision-making and increase
access to genetic services. Consideration of the patient/family
perspective and their decision-making processes, along with
flexibility in the approach to genetics evaluation and its timing,
will optimize both the development and implementation of
guidelines.
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Introduction
Approximately 1 in 500 babies are born with communicative-
ly significant hearing loss (Kemper and Downs 2000), and
early intervention is essential to optimize development of
speech and language (C. Yoshinaga-Itano 2003; Yoshinaga-
Itano et al. 1998). In 1999, Congress passed legislation that
provided funding to states to establish early hearing detection
and intervention (EHDI) programs (White 2003). The goal of
EHDI was to ensure that all newborns are screened for hearing
loss and that newborns who do not pass the screening receive
an audiologic diagnosis before 3 months of age, as well as
providing for early intervention.
Approximately 50% of hearing loss is genetic in etiology,
and this proportion is likely to increase as environmental
causes such as congenital rubella diminish in incidence.
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There are over 400 genetic syndromes that include hearing
loss (OMIM 2016), but most childhood hearing loss, approx-
imately 70% of cases, is non-syndromic or isolated hearing
loss (Morton 1991). Non-syndromic hearing loss displays re-
markable genetic heterogeneity, with over 90 genes identified
(Van Camp & Smith, 2016). Genetics consultation plays a
valuable role in the evaluation of childhood hearing loss in
identifying comorbidities and potential syndromes, as well as
specifying a molecular genetic etiology (Alford et al. 2014).
In parallel to the increasing number of young children di-
agnosed with hearing loss through newborn hearing screen-
ing, in the year 2000 the American College of Medical
Genetics (ACMG) issued a guideline that recommended a
genetic evaluation for all children with confirmed permanent
hearing loss (ACMG 2000), which was reinforced in 2014
(Alford et al. 2014). In general, the identification of a genetic
etiology allows for accurate recurrence chance counseling for
future siblings as well as the patient’s future offspring andmay
help support adaptation to the diagnosis by both the child and
the family (Biesecker and Erby 2008; Cohen and Biesecker
2010). However, the barriers to genetic testing in this popula-
tion are similar to those in patients with any inherited disorder,
including anxiety about learning information that one might
prefer not to know, the questionable reliability of test results,
and the potential negative influences of test results on repro-
ductive decision-making (Burton et al. 2006).
For hearing loss in particular, with a growing body of
genotype-phenotype correlations, genetic diagnosis may also
provide prognostic information regarding progression of hear-
ing loss and guide future management options (Morzaria et al.
2005). A practice survey from 2007 indicated that approxi-
mately half of clinicians will refer patients with hearing loss
for genetics consultation (Duncan et al. 2007); however, not
all parents or patients pursue the referral when it is offered.
There are many factors that play into the parental decision to
pursue this genetic evaluation, including parental perceptions,
family environment, and pediatrician involvement (Palmer
et al. 2009).
The patient/parent perspective on genetic evaluation of
hearing loss has been investigated in multiple previous stud-
ies. Most are survey-based, dating to the early years of genetic
testing for hearing loss (Brunger et al. 2000; Dagan et al.
2002; Martinez et al. 2003; Middleton et al. 2001;
Middleton et al. 1998; Palmer et al. 2008; Stern et al. 2002;
Taneja et al. 2004). Most studies targeted patients seen in the
genetics clinic and did not specify whether hearing loss was
nonsyndromic versus accompanied by comorbidities.
Considering the significant changes in genetic testing for hear-
ing loss, such as the availability of the OtoSCOPE panel in
2011 (Shearer et al. 2010), we sought to understand if the
conclusions from these earlier studies are still applicable to
the present day or generalizable to adults with hearing loss.
Therefore, we conducted 3 focus groups exploring the
perspectives of parents of children with hearing loss as well
as the perspectives of deaf adults. We included participants
who had had genetics evaluation as well as those who had
declined or had not had the opportunity for a genetics evalu-
ation. Finally, we explored differences in responses between
participants with nonsyndromic versus syndromic hearing
loss. We sought to identify current day motivators and barriers
to genetic testing and to define the attributes of a genetic
evaluation most valued by patients and parents. Our ultimate
goal is to improve patient care by helping clinicians under-
stand patients’ preferences for a genetics evaluation and to




Approval for the study was obtained from the University of
Michigan Institutional Review Board (Study Number
HUM00056347) with a waiver of documentation of informed
consent. Participants were recruited through the otolaryngol-
ogy clinics at the University of Michigan Health System and
the Michigan Hands and Voices support group listserv
(BMichigan Hands, and Voices Website,^ 2010) using a flyer
and email blasts. In order to protect participant confidentiality,
medical records were not accessed, and all demographic and
medical information was only available as volunteered by the
participants during the focus groups. Information regarding
the age of the individual with hearing loss was not specifically
collected.
Eligible participants included adults with hearing loss and
parents with at least one child with hearing loss between the
ages of 0 and 18 years. All participants communicated in
English or in American Sign Language (ASL), with inter-
preters available as needed. Participants were compensated
with $100 Visa gift cards obtained through the Human
Subject Incentive Payment Office.
Procedures
Two in-person focus group sessions were conducted with par-
ents, and one was conducted with adult participants. We refer
to the adult participants as Bdeaf adults^ since all had profound
hearing loss, whereas Bhearing loss^ is used to describe the
children, who had varying degrees of hearing loss. The focus
group sessions were moderated by a contracted independent
research consultant who followed a semi-structured focus
group discussion guide that was developed by the researchers.
The session began with an Bice-breaker^ period in which par-
ticipants shared their personal stories of hearing loss, followed
by discussion of sources of information and support,
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perceptions and utilization of genetic evaluation and genetic
testing for hearing loss, the characteristics of the Bideal^ ge-
netic test, and resources for learning about hearing loss and
genetics. During the Bice-breaker^ part of the session, themes
arose that were considered beyond the scope of the current
project, including delays in diagnosis of hearing loss, commu-
nication options and interventions for hearing loss, coping and
grief, and prenatal testing.
Follow up open-ended probes were used to elicit additional
information. Each session lasted approximately 2 h. All ses-
sions were audio recorded and transcribed, and two re-
searchers (EW, MML) were present to take notes during each
of the focus groups.
Data Analysis
The transcripts were reviewed by the principal investigator
(MML) to correct transcription errors and clarify questions
raised by the transcription process. A qualitative content anal-
ysis (Saldaña 2012) was performed using Dedoose software,
version 5.0.11 (SocioCultural Research Consultants, LLC,
Los Angeles, CA) www.dedoose.com. In the first level of
reading, two researchers (BMY and MML) reviewed the
transcripts to identify topics relevant to the discussions in all
3 focus groups. The code book was then generated from these
topics and applied to all 3 focus groups. Two (2) researchers
(TLM, BMY) then independently reviewed the transcripts and
assigned codes, and discrepancies were resolved.
The code book and the associated content was then sorted
by 3 reviewers (BMY, MML, TLM) into appropriate catego-
ries and clustered into major themes and subthemes, as de-
scribed (Saldaña 2012). Representative quotes were selected
to illustrate each subtheme, confirming the attribution of each
quote in order to ensure that multiple participants’ perspec-
tives were represented.
For each family, we coded whether or not they reported
undergoing a consultation with a geneticist, genetic testing,
or both. Some participants described genetic testing requested
by an otolaryngologist or another specialist, such as a cardi-
ologist; if a genetics consultation was not specifically men-
tioned, we coded the genetics consultation as unknown.
Family history and comorbidities were also noted.
Results
Patient Demographics
The sample included 28 total participants, of whom 23 were
parents representing 21 unique families, and 5 were adults
with hearing loss (Table 1). Of the 21 families represented
by parents, 13 reported comorbidities in their child with hear-
ing loss, 3 specifically mentioned the lack of comorbidities,
and for 5 families, comorbidities were coded as unknown.
Four (4) families had 2 children with hearing loss, and 1 of
these 4 also had additional relatives with hearing loss. In 3
families, the child with hearing loss was adopted. 12/21 fam-
ilies had pursued genetics consultations and/or genetic testing.
All parent participants were hearing.
Of the 5 deaf adults, English was the primary language for
3 participants, and ASL was the primary language for 2 par-
ticipants. None of the 5 deaf adults reported comorbidities,
and 3 deaf adults reported a family history of hearing loss in
at least one sibling. None of the deaf adults had undergone
genetic testing or had a genetics consultation, either as a child
or an adult. 3 of the deaf adults had children, all of whomwere
hearing.
Major Themes and Subthemes
Several subthemes emerged from the transcripts, which were
coalesced into 3 major themes: Desire for Knowledge,
Barriers to Genetic Evaluation and Testing, and Genetics
Clinic Experiences.
Desire for Knowledge
BDesire for Knowledge^ (Table 2) was a predominant reason
participants expressed interest in a genetics evaluation and
genetic testing. Several participants expressed the benefits of
detecting comorbidities, with vision concerns the most com-
monly mentioned. Parents were also clearly motivated to ob-
tain the best care possible for their children, which manifested
as a drive to explore every possible avenue of information that
could possibly impact their child’s future. For many, under-
standing the cause of their child’s hearing loss was felt to
influence educational choices or decisions for interventions
such as hearing aids.
Additional motivations underlying the BDesire for
Knowledge^ included family planning, curiosity, altruism,
non-hearing related health concerns, and development of the
child’s sense of identity. Interestingly, many participants were
not further able to define their desire for knowledge beyond
curiosity or Bwanting to know^ (Table 2). Participants were
interested in genetic testing to help provide answers regarding
the etiology of hearing loss, and some parents expressed a
desire to better address their child’s questions, in particular
the reasons why the child has hearing loss.
At the same time, many participants expressed ambiva-
lence about the impact of acquiring genetic knowledge. The
prospect of genetic knowledge elicited psychological tension
between the potential for increased worry versus the desire to
be better prepared and have better understanding. In fact,
some comments suggested that pursuing a genetic evalu-
ation could be perceived as a failure to accept the
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diagnosis of hearing loss, or even a failure of accepting
their child as he/she is (Table 2).
In contrast to ACMG guidelines (Alford et al. 2014), some
parents preferred to defer a genetic evaluation until their child
was of an age to decide for herself or himself, while acknowl-
edging the potential value of the information (Table 2).
Interestingly, while some of the deaf adults agreed with
waiting, others expressed an opposing preference and wished
that their parents had obtained this information on their behalf
when they were children (Table 2). These adults expressed no
concerns with the concept of their parents having made this
decision for them during childhood. It should be noted that
none of the deaf adults had had genetic testing as a child,
which is not surprising given that genetic testing for hearing
loss was not widely available 20 or more years ago. Although
they expressed curiosity as to the cause of hearing loss, none
had pursued a genetic evaluation as an adult.
Barriers to Genetic Evaluation
The second major theme concerned BBarriers to Genetic
Evaluation^ (Table 3). Some barriers were extrinsic and thus
independent of the participant’s desire to pursue evaluation,
such as difficulty with obtaining a referral or scheduling the
genetics evaluation, or financial concerns related to insurance
coverage. Nearly half (12/21) of the parents had pursued a
genetics evaluation, suggesting that extrinsic barriers were
not uniformly insurmountable. Financial considerations were
cited as impacting the decision to pursue genetic testing after
discussion with the geneticist. Referrals to the genetics clinic
came from a variety of providers, including otolaryngology,
primary care providers, and other specialists (such as cardi-
ology), in the cases where children were seeing multiple
physicians. Audiologists were seen as a source of infor-
mation, but many participants expected the genetics
Table 1 Demographic information






100 Parent (F) 1 child EVA; possible Pendred syndrome Yes Yes
103 Parent (F) 1 child Gastrostomy tube dependence Yes Yes
105 Parent (F) 1 child Congenital heart disease Yes Yes
109 Parent (F) 2 children EVA; Pendred syndrome Unknown Yes
119 Parent (F) 1 child Vision problem, prematurity (26 weeks) Yes Yes
120 Parent (M) 1 child Hypotonia, cognitive delay, possible fetal
alcohol syndrome
No No
121 Parent (F) 1 child Fetal hydrops, sensory processing disorder Unknown Yes
124 Parent (F) 1 child Heart defect, feeding tube dependence Yes No
125 Parent (F) 1 child Clinical diagnosis of Waardenburg syndrome Yes Yes
126 Parent (F) 1 child Dystonia, heart defect Yes Yes
101 Parent (F) 1 child Cerebral palsy No No
104 Parent (F) 1 child Brain damage No No
102 Parent (F) 2 children EVA No No
114 Parent (F) 2 children No Yes Yes
122 Parent (F) 1 child No No No
107 Parent (M) 1 child No Unknown Yes
106 Parents (F, M) 1 child Unknown No No
108 Parent (F) 1 child Unknown No No
110 Parent (F) 2 children, both maternal grandparents Unknown No Yes
112 Parents (F, M) 1 child Unknown No No
123 Parent (F) 1 child Unknown No No
115 Deaf adult (F) Participant and sibling Unknown No No
116 Deaf adult (M) Participant and his sibling Unknown No No
117 Deaf adult (F) Participant Unknown No No
118 Deaf adult (F) Participant Unknown No No
111 Deaf adult (F) Participant and her sibling Unknown No No
a as reported by participants since medical records were not reviewed
EVA = enlarged vestibular aqueduct
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Table 2 Desire for Knowledge with associated subthemes
Subtheme Family ID
Detect comorbidities
Some of the syndromes have other complications and I thought, well, if I waited that long or if I didn’t know about her hearing,
what if her eyes are next?
100, parent
There may be other things that you can do to help the child if you did know – I mean the other areas that you would need to watch
for, things that could be changing, too.
119, parent
I want them to test for things that may have an impact. If I knowmy son is going to likely lose his eyesight along with being deaf
then that might be [a] push more in the camp of, yeah I think I do want to pursue a cochlear implant for him because he’s not
going to have visual access to sign language as he gets older.
125, parent
Prepare for and optimize child’s future
Our son had gone through such a hard time getting diagnosed that I felt like I wanted to make sure we were on top of it with him
and that he wouldn’t have to go down the same road that [our older child, Bobby] had been down. So by doing the genetic testing,
our sole purpose was just to determine if there was a genetic component and, if so, so that we could help our child that was on the
way.
109, parent
Paving a path that’s best for your children I think is important and that’s the purpose of it…. If you know ahead of time that
potentially you’re going to lose your vision then, yeah, that helps you create a direction for your child, whether you’re going to
grow up in a Deaf culture or not.… You want your child to learn the best that they possibly can with whatever needs you can
provide for them. Yeah, as much genetic testing can done, I’m all for it.
120, parent
And that waymaybe you can help your child because if you know other kids have this, now you know away to teach them better.
Maybe they pick up on sign language faster or they pick up on reading lips so you kind of gear towards that to try to help them to
progress as best as possible.
124, parent
Wanting to know
I work in a scientific background and I just want to knowwhy. I mean I understand that it may not change the path but I just love
that knowledge. I want to know.
122, parent
I did want to know, is there a gene that he has that has either a connection with the congenital heart defect and hearing loss, or
hearing loss, because for his future, he’s going to have these questions. He’s starting to ask these questions…‘why me? Why
this? Why that?’ I want to have answers for him. So I’m trying to pursue every route I can.
105, parent
He’s going to be someday asking, BWhy am I deaf?^ Short of an BI don’t know^ – you know every family has different beliefs, or
a BGodmade you that way^ type of an answer, I think I feel like being able to tell him the scientific reason why he’s deaf the same
way that I can say to my biological daughter you have blue eyes because genetically this is what happened….For me I kind of feel




Yeah, it’s hard. It’s like you want to know, but it’s scary, too… there may be other things that you can do to help the child if you
did know.
119, parent
She seems so perfect and I don’t really care about a test. Then again I would like to get information so if she has questions for me
later I can say [what] this is…
112, parent
For some people it’s just being prepared and for other people it would mean okay, you have to worry about this for so long and
this could happen or if it never happens you’re still going to worry a lot of the time.
117, adult
Genetic testing, we decided against that. I mean, it wouldn’t have affected our decision to have children or not. We wanted a child
nomatter what. If we had done it, the only reason would be to mentally prepare ourselves. On the other hand, there [are] so many
resources out there. Children now are better off than I was.
115, adult
Timing of genetics evaluation
If it can answer a lot of questions, then I would definitely do it, but there’s so [many] unknowns right now that maybe I will wait
until they’re grown up and …maybe then we’ll have a lot more questions that they can answer.
107, parent
We feel if they want to pursue it and have that knowledge for themselves, thenwe will support that for them, but we don’t feel like
it’s a big issue for our family right now.
108, parent
When they get to the point if they want to know, there will probably be a lot more options out there for them to get tested too. 102, parent
I would have done it because I’m curious why or how I became deaf.…I kind of wish my parents did it just so I would know. 115, adult
My opinion is that I think parents could go ahead and test and figure out why they became deaf so maybe they could help them
with their language development.
118, adult
Wait and let them make the decision. Without them even knowing what’s going on, when they are old enough they can decide
themselves.
116, adult
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referral to come from their otolaryngologist and not
from their primary care physician.
We also identified intrinsic barriers that were personal to
the individual participant. Being overwhelmed by their
child’s hearing loss was a strong theme, and these parents
felt they were already dealing with more issues than they
could handle (Table 3). Many parents described a long
diagnostic odyssey before their child was accurately diag-
nosed with hearing loss, recounting a struggle to obtain the
necessary intervention for their child. As the counterpoint
to the participants who expressed a desire for knowledge to
discover comorbidities (Table 2), these parents expressed
reluctance to discover additional problems that might re-
quire their attention or cause more worry. For these par-
ents, genetics consultation and genetic testing were simply
not priorities (Table 3).
Finally, discussion regarding potential barriers to ge-
netic evaluation revealed opportunities for improving ed-
ucation regarding the process and benefits of a genetics
evaluation. In general, participants were not informed re-
garding the utility of diagnostic testing in the absence of a
family history (Table 3). Some formed their own conclu-
sion that the hearing loss resulted from acquired causes
unrelated to genetics (Table 3). Some participants could
not perceive any apparent value of genetic information if
it would not affect immediate medical care or impact fam-
ily planning decisions.
Genetics Clinic Experiences
The parents’ descriptions of their genetics clinic experi-
ences constituted the third major theme, BGenetics Clinic
Table 3 Barriers to Genetic
Evaluation and Testing Subtheme Family ID
Financial burden
At the time, it was like $360, that’s a lot of money. I’ve got young kids and that’s not going to
change anything.
111, adult
Would I have been interested in some future testing? I think so, just for that curiosity, but it




He’s a good doctor…I like him but I do get annoyed that I get blown off about it like it’s not
important and it’s not necessary
122, parent
…I was at the geneticist…. after I begged and pleaded with my pediatrician to get to him. 100, parent
Overwhelmed
Genetics is not my first priority. For him to hear, for him to just grow up like normal kids, is
my number one priority.
107, parent
..I just stopped it because this is my first child and it’s like my plate is already full. If they’re
trying to bring up something else that I’m not even [thinking of]…
126, parent
I was like okay, they’re alive and we got them through the NICU and all of that and really I
don’t want to add something more to it that’s not even on the radar.
119, parent
Honestly, with all the other stuff to take care of, genetic testing kind of takes a backseat….I
want to make sure that they’re getting the sound they need and they’re getting their speech
therapy and another appointment to go to, it’s kind of something that can wait until they’re
ready for it and they’re curious and they’ll learn more and we’ll learn more….And sometimes
with too much knowledge, it gets a little overwhelming.
102, parent
Educational opportunities
So I was actually under the impression that without her bio[logical] parents, she wasn’t able to
even find out information.
104, parent
I don’t know if maybe as I gave birth, she might have lost a little air at one point, you know? I
just don’t know. I know that palsy is kind of connected to hearing loss. Some kids have vision
problems with palsy. That might be her connection. We just don’t know.
101, parent
I talked to different physicians in the area and then I guess I determined whether or not I
thought they were credible or not based on what they said, which may or may not have been –
but I wasn’t going to settle for his future.
106, parent
I’m not very good at research and medical information sort of glazes over me so I would just
[go] to my doctor.
115, adult
I didn’t know that [genetic testing] was something that could be offered for people with
hearing impairment. You think of it as finding out if you’re predisposed to certain diseases but
I would never link it to something that could be wrong genetically that would cause the
hearing impairment.
123, parent
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Experiences^ (Table 4). Many parents offered realistic de-
scriptions of the evaluation process and manifested a good
understanding of the genetics of hearing loss. Regardless
of whether a definitive clinical or genetic diagnosis could
be made, many parents described positive experiences and
understood when to return for further evaluation in the
future. On the other hand, some respondents experienced
distress with the evaluation, either due to a feeling of
unease during the dysmorphology examination, or due to
unmet expectations. The identification of pertinent physi-
cal findings was sometimes perceived as a criticism or as
pointing out imperfections, and parents did not understand
how the physical findings were relevant to their child’s
hearing loss. One participant indicated that the genetics
clinic did not appear receptive or accustomed to evaluat-
ing a child with isolated hearing loss (Table 4).
Some parents described a significant investment of
time and effort to obtain the genetics consultation, only
to experience disappointment and unmet expectations.
Parents were frustrated and felt directed toward one op-
tion, such as deferring testing in the hope of a better and
more cost-effective future test, when their immediate de-
sire was to obtain testing. The lack of a definitive answer
was discouraging to some parents who were interested in
pursuing additional testing beyond what was currently
clinically available.
Impact of Comorbidities and Family History
We examined the impact of comorbidities on the likelihood of
pursuing genetics evaluation and/or genetic testing (Table 1).
As mentioned above, 13/21 families reported comorbidities in
their children with hearing loss, and for the other 8, comor-
bidity status was reported as negative or unknown. 4 of 13
with comorbidities had signs of a hearing loss syndrome
(Waardenburg syndrome or enlarged vestibular aqueduct/
Table 4 Genetics Clinic
Experience and Subthemes Subtheme Family ID
Positive experiences
So she said that they could actually do genetic testing to see if he has the gene that does not
interact well with the type of medication. I thought that was interesting…
105, parent
He does meet the criteria for Waardenburg Syndrome, and we did the genetic test for it, but it
came back negative for the type that they were testing….Come back in three or four years and
we’ll talk again about testing him again. In the meantime you have the clinical diagnosis…I’m
comfortable with the clinical diagnosis. I would love it if we could get that blood test and get
an answer and say yes this is for sure Waardenburg Syndrome because we have no other
information so we can’t look at a family history and say well he looks just like Uncle Bob so
it’s probably the same thing. Uncle Bob is doing just fine. It would be helpful for us to have
that and fill in the blanks a little bit.
125, parent
[Bobby] and my husband and I had [genetic testing], and then [Bobby] and my husband and I
both had the recessive gene that caused it in [Bobby]. [Sam] is not even a carrier. So he didn’t




But when I took her to genetics they were trying to find other problems…my thing was I was
trying to find out if it was something, if it could help me as far as her ear or maybe her
dystonia. I didn’t want them to try to find other things because I’m already dealing with a lot
so it just made me frustrated going to genetics...
126, parent
I hate them going oh well their finger is a quarter of an eighth of a centimeter too long.. It’s
hard to watch your perfect child be picked apart and you be told what’s wrong with them.
124, parent
…the first time [the clinic] called us, they said BWhat else does he have?^ and I thought, BIsn’t
that enough? Oh my gosh, you’re saying there’s more things.
109, parent
Unmet expectations
Once I was at the geneticist, he sort of discouraged us because he kept saying they were
having all these other tests and they were all being developed and it was sort of a bad time for
us to be asking for that genetic testing, that perhaps if we waited a year or a year and a half,
maybe our money would be better spent.
100, parent
When I did the genetic test, I mean, with the answer, I’m still not satisfied. I would like to
know more and more because at the end they were still saying, BWell, it’s a chance of 25%.^
114, parent
I think you need to be a good salesperson then, because had he said to me, not just that it’s
expensive, had he said to me, B$1500 and I can give you 60 genes and here’s why I think that
would be good,^ sold. I would have written him a check that day to find out, because we were
really antsy about getting there.
100, parent
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Pendred syndrome), and 3 of these 4 had undergone genetic
evaluation and/or genetic testing. Of the 9 other children with
comorbidities, 6 of the 9 had undergone either genetics eval-
uation and/or genetic testing.
With regard to family history, 4 of the 21 families
reported having 2 children with hearing loss. Three (3)
of these 4 families had pursued either a genetics con-
sultation and/or genetic testing. Thus, among the parents
of children with hearing loss, both the presence of co-
morbidities and a family history were drivers of genetics
consultation and/or genetic testing. However, a family
history of hearing loss did not appear to influence the
deaf adults in seeking genetics evaluation. None of the
deaf adults had had genetics consultation or genetic test-
ing, although 3 of the 5 deaf adults had a sibling with
hearing loss.
Discussion
Utilizing focus groups in an open-ended and thorough explo-
ration of the values associated with a genetic evaluation of
hearing loss, we were able to identify novel themes as well
as enduring ones. Previous studies explored the general topics
of genetics, newborn hearing screening, and molecular new-
born screening with students at Gallaudet University and par-
ents of children with hearing loss who had been evaluated in a
genetics clinic (results reported in two publications (Burton
et al. 2006; Withrow et al. 2008)). Other studies involved deaf
adults, hearing individuals, and parents of deaf children fo-
cused on self-identity and experiences of being Deaf as well as
the possible use of genetic testing for prenatal diagnosis or
termination of pregnancy (Guillemin and Gillam 2006).
Now that advances in genetic testing have made it possible
to define the molecular basis of hearing loss in an increasing
number of patients, it is possible to explore the rationale that
supports real world decision making, which is the unique per-
spective offered by our study.
We included individuals with long-established diagnoses
of hearing loss who reported on their actual behaviors in de-
ciding to pursue or not pursue a genetics evaluation. We be-
lieve this approach yields better insights into clinical decision-
making than posing hypothetical questions, such as whether
or not individuals would consider genetic testing if they had a
newborn with hearing loss (Martinez et al. 2003). In addition,
our study offers a broader perspective than most previous
studies by including participants (deaf adults and parents of
children with hearing loss) who did not seek genetics evalua-
tion. Participants in this study were recruited from
otolaryngology/audiology clinics and support groups rather
than from genetics clinics. As noted by Middleton et al.
(Middleton et al. 2010), engagement with deaf people is
critical in considering questions of genetics and
deafness, and therefore our study included deaf adults
to represent diverse communication methods and pro-
vide perspectives across the lifespan.
In 2007, Steinberg et al. used semi-structured interviews
with parents who had been referred but had not completed
genetics evaluation, finding that parents were motivated to pur-
sue genetic testing as a key step in learning more information
about the cause and origin of their child’s hearing loss. Genetic
testing was seen as a way to help prepare themselves and their
families for future children with hearing loss (Steinberg et al.
2007). Similar to our findings, this study also identified knowl-
edge gaps that represent opportunities to educate patients so
that they can make informed decisions regarding genetic eval-
uation. It has been noted that deaf people have less access to
health-related information because public health messages are
often transmitted through media only accessible to hearing in-
dividuals (Middleton et al. 2010). We found that participants
have their own preconceptions regarding genetics, such as as-
suming that hearing loss cannot be genetic in the absence of
other affected family members, or assuming that genetics eval-
uation cannot be done for an adopted child. In addition, the
participants may have their own explanations for the etiology
of hearing loss, such as birth trauma or postnatal infection.
Studies of parents receiving chromosome microarray results
noted similar contradictions in how parents interpreted genetic
information, including inaccurate understanding of variants of
uncertain significance as diagnostic and an explanation for their
child’s medical problems (Kiedrowski et al. 2015). As
expressed by Mulley et al. (2012), the misdiagnosis of patient
preferences has as much potential to cause harm as the misdi-
agnosis of the patient’smedical problem. In order for patients to
express their true treatment or outcome preference, they must
be informed of all options.
Multiple related studies that focused on the perspective of
parents of children with hearing loss presenting to the genetics
clinic found generally positive attitudes towards genetic test-
ing for hearing loss (Burton et al. 2006; Duncan et al. 2007;
Fisher et al. 2011; Kaimal et al. 2007; Ross et al. 2013).
Similar themes regarding desire for knowledge were elicited
from the parents in our focus groups and highlight the positive
attributes associated with understanding the genetic basis of
hearing loss. However, our findings also suggest that the ge-
netics clinic may be less accessible to children with isolated
deafness or deaf adults. For deaf adults, there is a paucity of
specialized clinics equivalent to those for cancer genetics/
genetic counseling or for prenatal genetic counseling through
an obstetrics clinic. Like many overburdened pediatric spe-
cialty clinics, the pediatric genetics clinic may need to priori-
tize access for patients with more severe health problems
(Hammers 2009; Kaye 2012). While genetic testing may be
done outside of the genetics clinic, patients have an on-going
need to access genetic counseling services, which usually re-
quires a visit to the genetics clinic.
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Although there was a strong theme among parents of chil-
dren with multiple medical problems of feeling overwhelmed,
also noted by Steinberg et al. (2007), many of these parents
had in fact pursued genetics evaluation. The uptake of genet-
ics services likely depends on whether or not a referral is
offered, and/or whether or not the referral is pursued by the
patient. Even though the majority of childhood hearing loss is
nonsyndromic, primary care physicians or specialists may be
more likely to initiate a genetics referral for children with
multiple comorbidities than for children with isolated hearing
loss. Educational efforts directed at primary care physicians
have emphasized the importance of considering a genetics
evaluation for patients with multiple congenital anomalies.
BGenetics red flags^ have been developed to assist in the
identification of individuals and families at increased risk of
a genetic diagnosis (Genetics in Primary Care Institute
Website," 2015; Whelan et al. 2004). However, the fact that
a genetics evaluation is indicated for any child with permanent
hearing loss may not have been as clearly communicated to
the primary care community. Our participants suggested that
their primary care physicians deferred consideration of a ge-
netics referral for hearing loss to the otolaryngologist. As the
specialists most qualified to identify hearing loss as a perma-
nent and possibly genetic condition, otolaryngologists should
be able to discuss the option of a genetic evaluation with their
patients. Defining specialty-specific Bgenetics red flags^ for
otolaryngologists may be helpful in this regard.
The question remains: when is the right time for a genetics
evaluation? Some parents may wish to see the geneticist as
soon as the diagnosis of hearing loss is made, while others
may need more time to come to terms with the diagnosis of
hearing loss and to overcome initial feelings of shock and grief
(McAllister et al. 2007; C Yoshinaga-Itano and Abdala de
Uzcategui 2001). Many parents opted to defer a decision until
more information could be obtained at some future indetermi-
nate date, until their child could decide as an adult, or until
new advances in diagnosis or intervention increased the value
of the genetics information for them. Some deaf adults agreed
with this approach, while others expressed a wish that their
parents had pursued genetic testing. Taking a flexible ap-
proach to the timing of a genetic evaluation, also recommend-
ed by Steinberg et al. (2007), defines a clear role for the man-
aging otolaryngologist or the primary care physician that re-
spects the autonomy of the patient. The provider should be
prepared to adapt to the patients’ needs at the time, and to
provide resources for use at a later date.
The findings of this study are limited by the sample size
and the potential for bias due to self-selection, which may
have led to a higher proportion of patients with comorbidities
than expected. Larger studies have identified cultural affilia-
tion as a predictor of motivations for genetic testing
(Boudreault et al. 2010). However, we did not specifically
ascertain cultural affiliation in our participants, and affiliation
cannot be inferred or assumed from communication method
alone (Boudreault et al. 2010). While the focus group format
allowed us to accommodate more participants than would
have been possible with one-on-one interviews, it also creates
a situation where individual participants may have had less
opportunity to give their opinion. Patient information was
self-reported, and medical records were not accessed. We
did not control for the duration of time since diagnosis of
hearing loss or genetic evaluation, which may have led to
recall bias. Participants were recruited from Michigan and
northern Ohio, and the results may not generalizable to a larg-
er population.
Remarkable advances in understanding the etiology of
hearing loss have occurred in recent years, with over 90
genes known to be involved in hearing loss [Smith and Van
Camp, 2016]. This remarkable genetic heterogeneity adds
additional complexity to the process of genetic testing for
hearing loss, which will only increase as more genes are
discovered. With the onset of next generation sequencing
technology, several multi-gene panels for hearing loss have
been developed that will allow more patients to receive a
timely molecular diagnosis at lower cost. Thus, the grow-
ing complexity of genetic information and the higher like-
lihood of identifying a genetic etiology for hearing loss
will make the utilization of genetics services increasingly
important. Our study brings the current literature up to date
and provides insight into the uptake of genetics services
15 years after the ACMG first issued guidelines that rec-
ommended genetics evaluation (ACMG 2000). Among the
families and patients with hearing loss who participated in
our study, 12/26 (46%) pursued genetics evaluation,
whichhighlights the importance of identifying opportuni-
ties to improve implementation of these guidelines. To this
end, we provide the following recommendations.
Recommendations:
1. Educate primary care physicians and otolaryngologists
regarding indications for genetics referral, so that they
may be a resource for participants to make informed de-
cisions, and provide referrals for patients that elect to pur-
sue it.
2. Guideline and policy development should take into con-
sideration the perspective of the patient/consumer, and
provide flexibility in terms of the timing of genetics
evaluation.
3. Education directed to deaf adults and parents of children
with hearing loss needs to address knowledge gaps and
employ various communication strategies to make this
information accessible to a diverse population.
4. Genetics clinics should take steps to explain the purpose
of the detailed physical examination, particularly for pa-
tients with nonsyndromic hearing loss, who may not see
themselves as Btypical^ genetics patients.
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5. Clinicians should take care to determine the family’s goals
and provide information while remaining non-directive in
their approach. The diagnosis of hearing loss and/or the
technical aspects of genetic information may be over-
whelming for parents and adult patients alike.
Conclusion
Our results suggest that the decision to pursue a genetic eval-
uation and genetic testing is complex and impacted by multi-
ple factors. These findings highlight the important role that
healthcare providers can play in ensuring that families have
time to fully explore perceived barriers to testing. In the future,
the development of evidence-based guidelines would help fa-
cilitate this recommended care by providing topics that pro-
viders should cover with patients and families.
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